Cipla Ltd
Cipla | 500087
Stock Performance
Ratios
About Company
- Cipla Limited is one of the leading pharmaceutical companies in India
- The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs)
- Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments
- With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets
- Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories
- Cipla Limited was incorporated in year 1935 with the name as 'Chemical, Industrial & Pharmaceutical Laboratories Limited'
- Khwaja Abdul Hamied, the founder of Cipla gave the company all his patent and proprietary formulas for several drugs and medicines, without charging any royalty
- On August 17, 1935, Cipla was registered as a public limited company with an authorized capital of Rs 6 lakh
- From its first manufacturing unit at Bombay Central in 1936, Cipla now has over 40 state-of-the art manufacturing facilities across the globe including India, USA, China and South Africa
- In the year 1941, as the Second World War cuts off drug supplies, the company starts producing fine chemicals, dedicating all its facilities for the war effort
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
News
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *

Frequently Asked Questions
What is Share Price of Cipla Ltd?
The current share price of Cipla Ltd (Cipla) is ₹1535.60. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Cipla Ltd?
The Price-to-Earnings (P/E) ratio of Cipla Ltd is 1535.60. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Cipla Ltd?
Cipla Ltd has a 52-week high of ₹1673.00 and a 52-week low of ₹1335.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Cipla Ltd?
Cipla Ltd offers a dividend yield of 1.04%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Cipla Ltd?
The Earnings Per Share (EPS) of Cipla Ltd is ₹67.36. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Cipla Ltd?
Cipla Ltd has a Return on Equity (ROE) of 17.17%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
